Specific Cytotoxicity of Targeted 177 Lu and 212 Pb-Based Radiopharmaceuticals
Specific Cytotoxicity of Targeted 177 Lu and 212 Pb-Based Radiopharmaceuticals
About this item
Full title
Specific Cytotoxicity of Targeted 177 Lu and 212 Pb-Based Radiopharmaceuticals
Author / Creator
Publisher
United States
Journal title
Bulletin of experimental biology and medicine, 2021-09, Vol.171 (5), p.627
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
Two radiopharmaceutical preparations were developed on the basis of artificial targeted polypeptide ZHER2 specific to HER2/neu tumor marker and radionuclides
Lu (ZHER2-HSA-chelator-
Lu) or
Pb (ZHER2-HSA-chelator-
Pb). The objective was to evaluate in vitro the cytotoxic activity of the targeted radiopharmaceuticals using two cultured hu...
Alternative Titles
Full title
Specific Cytotoxicity of Targeted 177 Lu and 212 Pb-Based Radiopharmaceuticals
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_34626281
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_34626281
Other Identifiers
E-ISSN
1573-8221
DOI
10.1007/s10517-021-05283-4
